Rinucumab (REGN 2176) 是一种单克隆抗体，是PDGF的抑制剂。Rinucumab (REGN 2176) 可用于新生血管性年龄相关性黄斑变性的研究。
| 生物活性 | Rinucumab (REGN 2176), a monoclonal antibody, is aPDGFinhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
